$600M Raised, Zero Survival: The Bankruptcy of Insect Farming Startup Ÿnsect

$600 million couldn't buy a revolution. Ÿnsect, the French startup that promised to transform the global food chain with mealworms, has officially entered judicial liquidation. Despite backing from high-profile investors like Robert Downey Jr.'s FootPrint Coalition and public bank Bpifrance, the company succumbed to insolvency, marking a somber end for one of Europe's most ambitious food-tech unicorns.

The High Cost of Strategic Indecision

Ÿnsect's downfall wasn't due to a lack of vision, but a lack of focus. For years, the company juggled three disparate markets: human food, pet food, and animal feed. Each has vastly different margins and economic realities. By the time they decided to pivot toward higher-margin segments in 2023, the financial damage was already irreparable. Revenue had peaked at just €17.8 million in 2021, while net losses ballooned to nearly €80 million two years later.

A Symptom of the European Scaling Gap

Industry experts point to Ÿnsect as a case study for Europe's struggle with industrialization. While the continent excels at funding moonshots and pilots, it often fails to bridge the gap to full-scale manufacturing. Ÿnsect committed to massive, capital-intensive infrastructure based on a sustainability thesis that collided with the brutal reality of commodity pricing. As Professor Joe Haslam of IE Business School noted, the struggle isn't about insects—it's about a mismatch between industrial ambition and capital market timing.